JPMorgan Starts Alnylam Pharmaceuticals (ALNY) at Overweight
Tweet
Share
E-mailGet Alerts ALNY Hot Sheet
Price: $145.79 --0%
Rating Summary:
24 Buy, 13 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 6
Rating Summary:
24 Buy, 13 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 6
Join SI Premium – FREE
JPMorgan initiates coverage on Alnylam Pharmaceuticals (NASDAQ: ALNY) with an Overweight. PT $15.00.
For an analyst ratings summary and ratings history on Alnylam Pharmaceuticals click here. For more ratings news on Alnylam Pharmaceuticals click here.
Shares of Alnylam Pharmaceuticals closed at $9.97 yesterday.
For an analyst ratings summary and ratings history on Alnylam Pharmaceuticals click here. For more ratings news on Alnylam Pharmaceuticals click here.
Shares of Alnylam Pharmaceuticals closed at $9.97 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Loop Capital Starts MongoDB (MDB) at Buy, '2H Ramp Ahead'
- Deutsche Bank Starts BioMerieux (BIM:FP) (BMXMF) at Buy
- Ambit Capital Starts Tata Technologies (TATATECH:IN) at Sell (4)
Create E-mail Alert Related Categories
New CoverageRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
